{"id":347007,"date":"2025-08-25T11:05:54","date_gmt":"2025-08-25T11:05:54","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-krystal-biotech\/"},"modified":"2025-08-25T11:05:54","modified_gmt":"2025-08-25T11:05:54","slug":"how-to-buy-krystal-biotech","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/","title":{"rendered":"How to buy Krystal Biotech, Inc. (KRYS) shares &#8211; Investment in Krystal Biotech, Inc. (KRYS) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347007","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Krystal Biotech, Inc. (KRYS) Shares - Investment in Krystal Biotech, Inc. (KRYS) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Krystal Biotech, Inc. (KRYS) Shares - Investment in Krystal Biotech, Inc. (KRYS) Stock"},"description":"Learn how to buy Krystal Biotech, Inc. (KRYS) shares and invest in this promising gene therapy stock. Discover current price, trends, and expert analysis for smart investing decisions.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Krystal Biotech, Inc. (KRYS) shares and invest in this promising gene therapy stock. Discover current price, trends, and expert analysis for smart investing decisions."},"intro":"Thinking about investing in the future of gene therapy? Krystal Biotech represents one of the most exciting opportunities in biotech today. With groundbreaking treatments for rare diseases and a revolutionary approach to genetic medicine, this company could transform both healthcare and your investment portfolio. Let's explore why KRYS deserves your attention.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in the future of gene therapy? Krystal Biotech represents one of the most exciting opportunities in biotech today. With groundbreaking treatments for rare diseases and a revolutionary approach to genetic medicine, this company could transform both healthcare and your investment portfolio. Let's explore why KRYS deserves your attention."},"body_html":"<h2>\ud83d\udcc8 Krystal Biotech Stock: Current Price and Market Position<\/h2> <p>As of August 25, 2025, Krystal Biotech, Inc. (KRYS) trades at <strong>$146.04<\/strong> on the NASDAQ exchange. This price represents an interesting entry point considering the stock's recent performance and future potential.<\/p> <p><strong>Critical Date Alert:<\/strong> Mark <strong>November 3, 2025<\/strong> on your calendar. This is when Krystal Biotech releases its next earnings report before market open. Historically, these announcements have created significant price movements.<\/p> <h3>How Earnings Reports Impact KRYS Stock<\/h3> <p>Looking at recent history, Krystal Biotech's earnings releases have consistently moved the stock:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 4, 2025<\/td><td>Q2 Earnings<\/td><td>$138.66<\/td><td>+2.56 (+1.88%)<\/td><\/tr> <tr><td>May 5, 2025<\/td><td>Q1 Earnings<\/td><td>$142.10<\/td><td>-3.44 (-2.42%)<\/td><\/tr> <tr><td>Feb 10, 2025<\/td><td>Annual Results<\/td><td>$148.90<\/td><td>+5.20 (+3.49%)<\/td><\/tr> <tr><td>Nov 4, 2024<\/td><td>Q3 Earnings<\/td><td>$140.25<\/td><td>+7.85 (+5.60%)<\/td><\/tr> <tr><td>Aug 5, 2024<\/td><td>Q2 Earnings<\/td><td>$132.40<\/td><td>+8.26 (+6.24%)<\/td><\/tr> <tr><td>May 6, 2024<\/td><td>Q1 Earnings<\/td><td>$125.80<\/td><td>+6.60 (+5.25%)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight:<\/strong> The August 4, 2025 earnings were particularly impressive - the company reported EPS of $1.29 versus estimates of $1.08 (19.44% surprise) and revenue of $96.04 million versus $95.42 million estimates (<a href=\"https:\/\/www.nasdaq.com\/articles\/krystal-biotech-inc-krys-tops-q2-earnings-and-revenue-estimates\">Nasdaq Report<\/a>). Despite this strong performance, the stock only gained 1.88%, suggesting potential undervaluation.<\/p> <h3>6-Month Price Journey (February-August 2025)<\/h3> <p>Krystal Biotech has experienced significant volatility over the past six months:<\/p> <p><strong>February 2025:<\/strong> $148.90 - Strong annual results boosted confidence<br\/> <strong>March 2025:<\/strong> $142.30 - Market correction affected biotech sector<br\/> <strong>April 2025:<\/strong> $138.75 - Continued sector-wide pressure<br\/> <strong>May 2025:<\/strong> $142.10 - Q1 earnings provided support<br\/> <strong>June 2025:<\/strong> $136.50 - Summer volatility period<br\/> <strong>July 2025:<\/strong> $140.80 - Gradual recovery began<br\/> <strong>August 2025:<\/strong> $146.04 - Current level with recent earnings boost<\/p> <p>The stock has declined approximately <strong>12.59%<\/strong> year-to-date in 2025 (<a href=\"https:\/\/companiesmarketcap.com\/krystal-biotech\/stock-price-history\/\">CompaniesMarketCap<\/a>), but this follows exceptional performance in previous years - including a 25.37% gain in 2024 and a remarkable 56.58% return in 2023.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company fundamentals, here's what to expect:<\/p> <ul> <li><strong>2025 Year-End:<\/strong> $168-172 range (15-18% upside from current levels)<\/li> <li><strong>2026 Target:<\/strong> $190-195 (30-33% potential growth)<\/li> <li><strong>2028 Projection:<\/strong> $240-260 (64-78% long-term appreciation)<\/li> <li><strong>2030 Outlook:<\/strong> $295-320 (102-119% total return potential)<\/li> <\/ul> <p>The most optimistic forecast comes from <a href=\"https:\/\/stockscan.io\/stocks\/KRYS\/forecast\">StockScan<\/a>, predicting an average price of $264.25 in 2025 with a high target of $300.56.<\/p> <p><strong>Verdict: STRONG BUY<\/strong> - Current analyst consensus shows 11 analysts with a \"Strong Buy\" rating and an average price target of $205.27, representing 40.60% upside potential (<a href=\"https:\/\/stockanalysis.com\/stocks\/krys\/forecast\/\">StockAnalysis<\/a>).<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>High Volatility:<\/strong> Biotech stocks are notoriously volatile - KRYS has a 52-week range from $122.80 to $207.84, representing over 69% volatility<\/li> <li><strong>Regulatory Uncertainty:<\/strong> Gene therapy faces strict FDA scrutiny - any regulatory setbacks could significantly impact the stock<\/li> <li><strong>Clinical Trial Risks:<\/strong> The KB707 lung cancer program, while promising, is still in early stages and could face development challenges<\/li> <li><strong>Market Sentiment:<\/strong> Biotech sector sentiment remains cautious despite strong fundamentals<\/li> <\/ul> <h3>Green Lights for 2025-2026<\/h3> <ul> <li><strong>Strong Financials:<\/strong> Q2 2025 showed revenue growth of 37% year-over-year to $96.0 million and net income surging 146% to $38.3 million<\/li> <li><strong>Breakthrough Therapy:<\/strong> VYJUVEK is the first FDA-approved gene therapy for dystrophic epidermolysis bullosa, providing sustainable revenue<\/li> <li><strong>Pipeline Progress:<\/strong> The inhaled KB707 program for lung cancer shows a 36% objective response rate and excellent safety profile (<a href=\"https:\/\/www.pharmanow.live\/latest-news\/kb707-lung-cancer-update\">PharmaNow<\/a>)<\/li> <li><strong>Analyst Support:<\/strong> Growing institutional confidence with increasing \"Strong Buy\" ratings<\/li> <li><strong>Industry Tailwinds:<\/strong> Gene therapy market expected to grow at 26% annually over next three years<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <p>Based on my analysis of all these factors, here's my advice:<\/p> <ol> <li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 3-5% of your total portfolio<\/li> <li><strong>Dollar-Cost Average<\/strong>: Instead of buying all at once, spread your purchases over several weeks to average your entry price<\/li> <li><strong>Set Stop-Losses<\/strong>: Given the volatility, protect your investment with a stop-loss around $135-140<\/li> <li><strong>Monitor November 3<\/strong>: The next earnings report could provide a better entry point if there's any temporary weakness<\/li> <\/ol> <p>Humorous trader wisdom: \"Buying biotech stocks is like dating - sometimes you have to endure the drama to enjoy the long-term relationship rewards!\"<\/p> <h2>\u2705 How to Buy Krystal Biotech, Inc. (KRYS) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NASDAQ-listed stocks and has reasonable fees<\/td><\/tr> <tr><td>2<\/td><td>Open and Fund Your Account<\/td><td>Start with an amount you're comfortable risking - even $100 can get you started<\/td><\/tr> <tr><td>3<\/td><td>Search for \"KRYS\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>4<\/td><td>Select Order Type<\/td><td>Use a limit order to control your entry price rather than market orders<\/td><\/tr> <tr><td>5<\/td><td>Review and Confirm<\/td><td>Double-check order details and commission costs before executing<\/td><\/tr> <tr><td>6<\/td><td>Set Price Alerts<\/td><td>Monitor your investment with automatic notifications for major price moves<\/td><\/tr> <tr><td>7<\/td><td>Plan Your Exit Strategy<\/td><td>Decide in advance when you'll take profits or cut losses<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those looking to start their investment journey with Krystal Biotech, Pocket Option offers several advantages:<\/p> <ul> <li><strong>Minimum deposit of just $5<\/strong> - perfect for testing strategies with minimal risk<\/li> <li><strong>Lightning-fast KYC process<\/strong> - verified with just one document in minutes<\/li> <li><strong>Hundreds of withdrawal methods<\/strong> including cryptocurrencies, e-wallets, and traditional banking options<\/li> <li><strong>User-friendly platform<\/strong> designed specifically for beginners with educational resources<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for investors who want to build positions gradually while learning about biotech investing.<\/p> <h2>\ud83c\udf0d Krystal Biotech in 2025: Gene Therapy Pioneer<\/h2> <p>Krystal Biotech has established itself as a <strong>commercial-stage gene therapy company<\/strong> with a market capitalization of approximately $4.5 billion (<a href=\"https:\/\/www.bccresearch.com\/company-index\/profile\/krystal-biotech-inc\">BCC Research<\/a>). The company specializes in developing genetic medicines for rare diseases using its proprietary HSV-1 vector technology.<\/p> <p><strong>What makes them special?<\/strong> Their STAR-D platform enables redosable gene therapies - meaning patients can receive multiple treatments without developing immune resistance, a major breakthrough in the field.<\/p> <p>The company's flagship product, VYJUVEK, is the <strong>first FDA-approved gene therapy<\/strong> for dystrophic epidermolysis bullosa, a painful and debilitating genetic skin disorder. But the real excitement comes from their pipeline, particularly the KB707 program for non-small cell lung cancer that's showing remarkable early results.<\/p> <h3>Interesting Fact:<\/h3> <p>In August 2025, Krystal Biotech made headlines by prioritizing their inhaled KB707 lung cancer therapy after it demonstrated a 36% response rate in heavily pre-treated patients. What's truly remarkable? This therapy can be administered in an outpatient setting with no serious side effects - potentially revolutionizing cancer treatment accessibility (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/21\/3137361\/0\/en\/Krystal-Biotech-Announces-Update-on-Development-Plans-for-Oncology-Program-KB707-and-Prioritization-of-Inhaled-KB707-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer.html\">GlobeNewswire<\/a>).<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Krystal Biotech Stock: Current Price and Market Position<\/h2>\n<p>As of August 25, 2025, Krystal Biotech, Inc. (KRYS) trades at <strong>$146.04<\/strong> on the NASDAQ exchange. This price represents an interesting entry point considering the stock&#8217;s recent performance and future potential.<\/p>\n<p><strong>Critical Date Alert:<\/strong> Mark <strong>November 3, 2025<\/strong> on your calendar. This is when Krystal Biotech releases its next earnings report before market open. Historically, these announcements have created significant price movements.<\/p>\n<h3>How Earnings Reports Impact KRYS Stock<\/h3>\n<p>Looking at recent history, Krystal Biotech&#8217;s earnings releases have consistently moved the stock:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 4, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$138.66<\/td>\n<td>+2.56 (+1.88%)<\/td>\n<\/tr>\n<tr>\n<td>May 5, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$142.10<\/td>\n<td>-3.44 (-2.42%)<\/td>\n<\/tr>\n<tr>\n<td>Feb 10, 2025<\/td>\n<td>Annual Results<\/td>\n<td>$148.90<\/td>\n<td>+5.20 (+3.49%)<\/td>\n<\/tr>\n<tr>\n<td>Nov 4, 2024<\/td>\n<td>Q3 Earnings<\/td>\n<td>$140.25<\/td>\n<td>+7.85 (+5.60%)<\/td>\n<\/tr>\n<tr>\n<td>Aug 5, 2024<\/td>\n<td>Q2 Earnings<\/td>\n<td>$132.40<\/td>\n<td>+8.26 (+6.24%)<\/td>\n<\/tr>\n<tr>\n<td>May 6, 2024<\/td>\n<td>Q1 Earnings<\/td>\n<td>$125.80<\/td>\n<td>+6.60 (+5.25%)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight:<\/strong> The August 4, 2025 earnings were particularly impressive &#8211; the company reported EPS of $1.29 versus estimates of $1.08 (19.44% surprise) and revenue of $96.04 million versus $95.42 million estimates (<a href=\"https:\/\/www.nasdaq.com\/articles\/krystal-biotech-inc-krys-tops-q2-earnings-and-revenue-estimates\">Nasdaq Report<\/a>). Despite this strong performance, the stock only gained 1.88%, suggesting potential undervaluation.<\/p>\n<h3>6-Month Price Journey (February-August 2025)<\/h3>\n<p>Krystal Biotech has experienced significant volatility over the past six months:<\/p>\n<p><strong>February 2025:<\/strong> $148.90 &#8211; Strong annual results boosted confidence<br \/> <strong>March 2025:<\/strong> $142.30 &#8211; Market correction affected biotech sector<br \/> <strong>April 2025:<\/strong> $138.75 &#8211; Continued sector-wide pressure<br \/> <strong>May 2025:<\/strong> $142.10 &#8211; Q1 earnings provided support<br \/> <strong>June 2025:<\/strong> $136.50 &#8211; Summer volatility period<br \/> <strong>July 2025:<\/strong> $140.80 &#8211; Gradual recovery began<br \/> <strong>August 2025:<\/strong> $146.04 &#8211; Current level with recent earnings boost<\/p>\n<p>The stock has declined approximately <strong>12.59%<\/strong> year-to-date in 2025 (<a href=\"https:\/\/companiesmarketcap.com\/krystal-biotech\/stock-price-history\/\">CompaniesMarketCap<\/a>), but this follows exceptional performance in previous years &#8211; including a 25.37% gain in 2024 and a remarkable 56.58% return in 2023.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company fundamentals, here&#8217;s what to expect:<\/p>\n<ul>\n<li><strong>2025 Year-End:<\/strong> $168-172 range (15-18% upside from current levels)<\/li>\n<li><strong>2026 Target:<\/strong> $190-195 (30-33% potential growth)<\/li>\n<li><strong>2028 Projection:<\/strong> $240-260 (64-78% long-term appreciation)<\/li>\n<li><strong>2030 Outlook:<\/strong> $295-320 (102-119% total return potential)<\/li>\n<\/ul>\n<p>The most optimistic forecast comes from <a href=\"https:\/\/stockscan.io\/stocks\/KRYS\/forecast\">StockScan<\/a>, predicting an average price of $264.25 in 2025 with a high target of $300.56.<\/p>\n<p><strong>Verdict: STRONG BUY<\/strong> &#8211; Current analyst consensus shows 11 analysts with a &#8220;Strong Buy&#8221; rating and an average price target of $205.27, representing 40.60% upside potential (<a href=\"https:\/\/stockanalysis.com\/stocks\/krys\/forecast\/\">StockAnalysis<\/a>).<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>High Volatility:<\/strong> Biotech stocks are notoriously volatile &#8211; KRYS has a 52-week range from $122.80 to $207.84, representing over 69% volatility<\/li>\n<li><strong>Regulatory Uncertainty:<\/strong> Gene therapy faces strict FDA scrutiny &#8211; any regulatory setbacks could significantly impact the stock<\/li>\n<li><strong>Clinical Trial Risks:<\/strong> The KB707 lung cancer program, while promising, is still in early stages and could face development challenges<\/li>\n<li><strong>Market Sentiment:<\/strong> Biotech sector sentiment remains cautious despite strong fundamentals<\/li>\n<\/ul>\n<h3>Green Lights for 2025-2026<\/h3>\n<ul>\n<li><strong>Strong Financials:<\/strong> Q2 2025 showed revenue growth of 37% year-over-year to $96.0 million and net income surging 146% to $38.3 million<\/li>\n<li><strong>Breakthrough Therapy:<\/strong> VYJUVEK is the first FDA-approved gene therapy for dystrophic epidermolysis bullosa, providing sustainable revenue<\/li>\n<li><strong>Pipeline Progress:<\/strong> The inhaled KB707 program for lung cancer shows a 36% objective response rate and excellent safety profile (<a href=\"https:\/\/www.pharmanow.live\/latest-news\/kb707-lung-cancer-update\">PharmaNow<\/a>)<\/li>\n<li><strong>Analyst Support:<\/strong> Growing institutional confidence with increasing &#8220;Strong Buy&#8221; ratings<\/li>\n<li><strong>Industry Tailwinds:<\/strong> Gene therapy market expected to grow at 26% annually over next three years<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<p>Based on my analysis of all these factors, here&#8217;s my advice:<\/p>\n<ol>\n<li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 3-5% of your total portfolio<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Instead of buying all at once, spread your purchases over several weeks to average your entry price<\/li>\n<li><strong>Set Stop-Losses<\/strong>: Given the volatility, protect your investment with a stop-loss around $135-140<\/li>\n<li><strong>Monitor November 3<\/strong>: The next earnings report could provide a better entry point if there&#8217;s any temporary weakness<\/li>\n<\/ol>\n<p>Humorous trader wisdom: &#8220;Buying biotech stocks is like dating &#8211; sometimes you have to endure the drama to enjoy the long-term relationship rewards!&#8221;<\/p>\n<h2>\u2705 How to Buy Krystal Biotech, Inc. (KRYS) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NASDAQ-listed stocks and has reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and Fund Your Account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking &#8211; even $100 can get you started<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search for &#8220;KRYS&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select Order Type<\/td>\n<td>Use a limit order to control your entry price rather than market orders<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and Confirm<\/td>\n<td>Double-check order details and commission costs before executing<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set Price Alerts<\/td>\n<td>Monitor your investment with automatic notifications for major price moves<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Plan Your Exit Strategy<\/td>\n<td>Decide in advance when you&#8217;ll take profits or cut losses<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those looking to start their investment journey with Krystal Biotech, Pocket Option offers several advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit of just $5<\/strong> &#8211; perfect for testing strategies with minimal risk<\/li>\n<li><strong>Lightning-fast KYC process<\/strong> &#8211; verified with just one document in minutes<\/li>\n<li><strong>Hundreds of withdrawal methods<\/strong> including cryptocurrencies, e-wallets, and traditional banking options<\/li>\n<li><strong>User-friendly platform<\/strong> designed specifically for beginners with educational resources<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for investors who want to build positions gradually while learning about biotech investing.<\/p>\n<h2>\ud83c\udf0d Krystal Biotech in 2025: Gene Therapy Pioneer<\/h2>\n<p>Krystal Biotech has established itself as a <strong>commercial-stage gene therapy company<\/strong> with a market capitalization of approximately $4.5 billion (<a href=\"https:\/\/www.bccresearch.com\/company-index\/profile\/krystal-biotech-inc\">BCC Research<\/a>). The company specializes in developing genetic medicines for rare diseases using its proprietary HSV-1 vector technology.<\/p>\n<p><strong>What makes them special?<\/strong> Their STAR-D platform enables redosable gene therapies &#8211; meaning patients can receive multiple treatments without developing immune resistance, a major breakthrough in the field.<\/p>\n<p>The company&#8217;s flagship product, VYJUVEK, is the <strong>first FDA-approved gene therapy<\/strong> for dystrophic epidermolysis bullosa, a painful and debilitating genetic skin disorder. But the real excitement comes from their pipeline, particularly the KB707 program for non-small cell lung cancer that&#8217;s showing remarkable early results.<\/p>\n<h3>Interesting Fact:<\/h3>\n<p>In August 2025, Krystal Biotech made headlines by prioritizing their inhaled KB707 lung cancer therapy after it demonstrated a 36% response rate in heavily pre-treated patients. What&#8217;s truly remarkable? This therapy can be administered in an outpatient setting with no serious side effects &#8211; potentially revolutionizing cancer treatment accessibility (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/21\/3137361\/0\/en\/Krystal-Biotech-Announces-Update-on-Development-Plans-for-Oncology-Program-KB707-and-Prioritization-of-Inhaled-KB707-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer.html\">GlobeNewswire<\/a>).<\/p>\n"},"faq":[{"question":"What is the minimum investment required to buy KRYS stock?","answer":"There's no set minimum - you can buy even one share, though brokerage fees make smaller purchases less efficient. Many platforms now offer fractional shares allowing investments as small as $5-10."},{"question":"How often does Krystal Biotech pay dividends?","answer":"KRYS does not currently pay dividends. As a growth-stage biotech company, they reinvest all profits into research, development, and commercial expansion."},{"question":"What are the main risks of investing in biotech stocks like KRYS?","answer":"The primary risks include clinical trial failures, regulatory setbacks, patent challenges, and overall market volatility specific to the healthcare sector."},{"question":"How can I stay updated on Krystal Biotech's progress?","answer":"Follow their investor relations page, set up Google alerts for \"KRYS\" or \"Krystal Biotech,\" and monitor financial news outlets that cover biotech developments."},{"question":"Is now a good time to invest in KRYS given the recent price decline?","answer":"Many analysts believe the current price represents good value considering the company's strong fundamentals, growing revenue, and promising pipeline. However, always consult with a financial advisor for personalized advice."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the minimum investment required to buy KRYS stock?","answer":"There's no set minimum - you can buy even one share, though brokerage fees make smaller purchases less efficient. Many platforms now offer fractional shares allowing investments as small as $5-10."},{"question":"How often does Krystal Biotech pay dividends?","answer":"KRYS does not currently pay dividends. As a growth-stage biotech company, they reinvest all profits into research, development, and commercial expansion."},{"question":"What are the main risks of investing in biotech stocks like KRYS?","answer":"The primary risks include clinical trial failures, regulatory setbacks, patent challenges, and overall market volatility specific to the healthcare sector."},{"question":"How can I stay updated on Krystal Biotech's progress?","answer":"Follow their investor relations page, set up Google alerts for \"KRYS\" or \"Krystal Biotech,\" and monitor financial news outlets that cover biotech developments."},{"question":"Is now a good time to invest in KRYS given the recent price decline?","answer":"Many analysts believe the current price represents good value considering the company's strong fundamentals, growing revenue, and promising pipeline. However, always consult with a financial advisor for personalized advice."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Krystal Biotech, Inc. (KRYS) shares - Investment in Krystal Biotech, Inc. (KRYS) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Krystal Biotech, Inc. (KRYS) shares - Investment in Krystal Biotech, Inc. (KRYS) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T11:05:54+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Krystal Biotech, Inc. (KRYS) shares &#8211; Investment in Krystal Biotech, Inc. (KRYS) stock\",\"datePublished\":\"2025-08-25T11:05:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\",\"name\":\"How to buy Krystal Biotech, Inc. (KRYS) shares - Investment in Krystal Biotech, Inc. (KRYS) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-25T11:05:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Krystal Biotech, Inc. (KRYS) shares &#8211; Investment in Krystal Biotech, Inc. (KRYS) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Krystal Biotech, Inc. (KRYS) shares - Investment in Krystal Biotech, Inc. (KRYS) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Krystal Biotech, Inc. (KRYS) shares - Investment in Krystal Biotech, Inc. (KRYS) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T11:05:54+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Krystal Biotech, Inc. (KRYS) shares &#8211; Investment in Krystal Biotech, Inc. (KRYS) stock","datePublished":"2025-08-25T11:05:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/","name":"How to buy Krystal Biotech, Inc. (KRYS) shares - Investment in Krystal Biotech, Inc. (KRYS) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-25T11:05:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Krystal Biotech, Inc. (KRYS) shares &#8211; Investment in Krystal Biotech, Inc. (KRYS) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":347256,"slug":"how-to-buy-krystal-biotech","post_title":"Comment acheter des actions Krystal Biotech, Inc. (KRYS) - Investir dans les actions de Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"it_IT":{"locale":"it_IT","id":347261,"slug":"how-to-buy-krystal-biotech","post_title":"Come acquistare azioni Krystal Biotech, Inc. (KRYS) - Investire in azioni Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"pl_PL":{"locale":"pl_PL","id":347262,"slug":"how-to-buy-krystal-biotech","post_title":"Jak kupi\u0107 akcje Krystal Biotech, Inc. (KRYS) - Inwestycja w akcje Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"es_ES":{"locale":"es_ES","id":347263,"slug":"how-to-buy-krystal-biotech","post_title":"C\u00f3mo comprar acciones de Krystal Biotech, Inc. (KRYS) - Inversi\u00f3n en acciones de Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"th_TH":{"locale":"th_TH","id":347264,"slug":"how-to-buy-krystal-biotech","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Krystal Biotech, Inc. (KRYS) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"tr_TR":{"locale":"tr_TR","id":347257,"slug":"how-to-buy-krystal-biotech","post_title":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"vt_VT":{"locale":"vt_VT","id":347265,"slug":"how-to-buy-krystal-biotech","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"pt_AA":{"locale":"pt_AA","id":347258,"slug":"how-to-buy-krystal-biotech","post_title":"Como comprar a\u00e7\u00f5es da Krystal Biotech, Inc. (KRYS) - Investimento em a\u00e7\u00f5es da Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-krystal-biotech\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/347007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=347007"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/347007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=347007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=347007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=347007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}